Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | abcb9, putative | 0.0125 | 0.0796 | 0.6836 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0125 | 0.0796 | 0.6836 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0125 | 0.0796 | 0.6836 |
Loa Loa (eye worm) | aspartic protease BmAsp-2 | 0.0156 | 0.1114 | 0.5897 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0125 | 0.0796 | 0.6836 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0125 | 0.0796 | 0.6836 |
Schistosoma mansoni | multidrug resistance protein | 0.0125 | 0.0796 | 0.1628 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0125 | 0.0796 | 0.6836 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0125 | 0.0796 | 0.6836 |
Loa Loa (eye worm) | hypothetical protein | 0.0067 | 0.0212 | 0.1122 |
Onchocerca volvulus | 0.0125 | 0.0796 | 1 | |
Toxoplasma gondii | ABC transporter transmembrane region domain-containing protein | 0.0125 | 0.0796 | 0.7143 |
Schistosoma mansoni | smdr2 | 0.0125 | 0.0796 | 0.1628 |
Plasmodium falciparum | plasmepsin X | 0.0125 | 0.0799 | 0.7176 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0125 | 0.0796 | 0.6836 |
Plasmodium falciparum | sphingomyelin synthase 1, putative | 0.0056 | 0.0108 | 0.0971 |
Plasmodium falciparum | sphingomyelin synthase 2, putative | 0.0056 | 0.0108 | 0.0971 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.0108 | 0.0573 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.0108 | 0.0573 |
Schistosoma mansoni | spingomyelin synthetase-related | 0.0056 | 0.0108 | 0.0221 |
Plasmodium falciparum | plasmepsin IV | 0.0156 | 0.1114 | 1 |
Trypanosoma brucei | sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional | 0.0533 | 0.4909 | 1 |
Entamoeba histolytica | P-glycoprotein-5 | 0.0125 | 0.0796 | 0.0695 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0087 | 0.0417 | 0.3072 |
Entamoeba histolytica | P-glycoprotein-2 | 0.0125 | 0.0796 | 0.0695 |
Toxoplasma gondii | aspartyl protease ASP3 | 0.0125 | 0.0799 | 0.7176 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.0087 | 0.0417 | 0.3072 |
Plasmodium falciparum | multidrug resistance protein 1 | 0.0125 | 0.0796 | 0.7143 |
Brugia malayi | Sphingomyelin synthase-related 1 | 0.0056 | 0.0108 | 0.0573 |
Plasmodium falciparum | plasmepsin I | 0.0156 | 0.1114 | 1 |
Trypanosoma brucei | sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional | 0.0533 | 0.4909 | 1 |
Trichomonas vaginalis | ABC transporter, putative | 0.0125 | 0.0796 | 0.6836 |
Echinococcus multilocularis | ATP binding cassette sub family B | 0.0123 | 0.0782 | 0.67 |
Schistosoma mansoni | multidrug resistance protein | 0.0125 | 0.0796 | 0.1628 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.0125 | 0.0796 | 0.6836 |
Entamoeba histolytica | P-glyco protein 6, putative | 0.0125 | 0.0796 | 0.0695 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0125 | 0.0796 | 0.6836 |
Leishmania major | phosphatidylcholine:ceramide cholinephosphotransferase 2 | 0.0533 | 0.4909 | 1 |
Plasmodium vivax | plasmepsin IV, putative | 0.0156 | 0.1114 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0125 | 0.0796 | 0.6836 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0097 | 0.0522 | 0.2763 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.0108 | 0.0573 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0125 | 0.0796 | 0.6836 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0125 | 0.0796 | 0.6836 |
Plasmodium falciparum | sphingomyelin synthase 1, putative | 0.0056 | 0.0108 | 0.0971 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0067 | 0.0212 | 0.1122 |
Trichomonas vaginalis | ABC transporter, putative | 0.0125 | 0.0796 | 0.6836 |
Chlamydia trachomatis | ABC transporter ATP binding protein/permease | 0.0125 | 0.0796 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.0108 | 0.0573 |
Brugia malayi | Phosphatidylcholine:ceramide cholinephosphotransferase 3 | 0.0056 | 0.0108 | 0.0573 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0125 | 0.0796 | 0.6836 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0233 | 0.1889 | 1 |
Trypanosoma cruzi | sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional | 0.0533 | 0.4909 | 0.5 |
Trichomonas vaginalis | Clan AA, family A1, cathepsin D-like aspartic peptidase | 0.0156 | 0.1114 | 1 |
Schistosoma mansoni | cathepsin D (A01 family) | 0.0531 | 0.489 | 1 |
Trichomonas vaginalis | abcb9, putative | 0.0125 | 0.0796 | 0.6836 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0125 | 0.0796 | 0.6836 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0125 | 0.0796 | 0.6836 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.0125 | 0.0796 | 0.6836 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0125 | 0.0796 | 0.6836 |
Trichomonas vaginalis | ABC transporter, half transporter, putative | 0.0125 | 0.0796 | 0.6836 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0125 | 0.0796 | 0.6836 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0125 | 0.0796 | 0.6836 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0125 | 0.0796 | 0.6836 |
Loa Loa (eye worm) | hypothetical protein | 0.0156 | 0.1114 | 0.5897 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0125 | 0.0796 | 0.6836 |
Echinococcus granulosus | 5'partial|ATP binding cassette sub family B | 0.0123 | 0.0782 | 0.67 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0087 | 0.0417 | 0.3072 |
Loa Loa (eye worm) | hypothetical protein | 0.0097 | 0.0522 | 0.2763 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0125 | 0.0796 | 0.6836 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0125 | 0.0796 | 0.6836 |
Toxoplasma gondii | hypothetical protein | 0.0056 | 0.0108 | 0.0971 |
Trichomonas vaginalis | ABC transporter, putative | 0.0125 | 0.0796 | 0.6836 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0125 | 0.0796 | 0.6836 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0125 | 0.0796 | 0.6836 |
Entamoeba histolytica | P-glycoprotein-2 | 0.0125 | 0.0796 | 0.0695 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.0108 | 0.0573 |
Trichomonas vaginalis | abcb9, putative | 0.0125 | 0.0796 | 0.6836 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0125 | 0.0796 | 0.6836 |
Entamoeba histolytica | P-glycoprotein-1 | 0.0125 | 0.0796 | 0.0695 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0125 | 0.0796 | 0.6836 |
Plasmodium vivax | sphingomyelin synthase 1, putative | 0.0056 | 0.0108 | 0.0971 |
Brugia malayi | ABC transporter family protein | 0.0125 | 0.0796 | 0.4213 |
Loa Loa (eye worm) | hypothetical protein | 0.0125 | 0.0796 | 0.4213 |
Trichomonas vaginalis | ABC transporter, putative | 0.0125 | 0.0796 | 0.6836 |
Plasmodium falciparum | plasmepsin IX | 0.0125 | 0.0799 | 0.7176 |
Schistosoma mansoni | hypothetical protein | 0.0067 | 0.0212 | 0.0433 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.0108 | 0.0573 |
Trichomonas vaginalis | ABC transporter, half transporter, putative | 0.0125 | 0.0796 | 0.6836 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0125 | 0.0796 | 0.6836 |
Plasmodium falciparum | plasmepsin II | 0.0156 | 0.1114 | 1 |
Loa Loa (eye worm) | multidrug resistance protein 3 | 0.0125 | 0.0796 | 0.4213 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0125 | 0.0796 | 0.6836 |
Echinococcus multilocularis | cathepsin d (lysosomal aspartyl protease) | 0.0156 | 0.1114 | 1 |
Brugia malayi | Phosphatidylcholine:ceramide cholinephosphotransferase 2 | 0.0056 | 0.0108 | 0.0573 |
Echinococcus granulosus | cathepsin d lysosomal aspartyl protease | 0.0156 | 0.1114 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0097 | 0.0522 | 0.2763 |
Plasmodium falciparum | plasmepsin VI | 0.0156 | 0.1114 | 1 |
Schistosoma mansoni | multidrug resistance protein | 0.0125 | 0.0796 | 0.1628 |
Plasmodium vivax | multidrug resistance protein 1, putative | 0.0125 | 0.0796 | 0.7143 |
Brugia malayi | MH2 domain containing protein | 0.0233 | 0.1889 | 1 |
Schistosoma mansoni | cathepsin D (A01 family) | 0.0531 | 0.489 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0233 | 0.1889 | 1 |
Trichomonas vaginalis | taga, putative | 0.0125 | 0.0796 | 0.6836 |
Loa Loa (eye worm) | hypothetical protein | 0.0125 | 0.0796 | 0.4213 |
Plasmodium vivax | sphingomyelin synthase 2, putative | 0.0056 | 0.0108 | 0.0971 |
Toxoplasma gondii | ATP-binding cassette transporter ABC.B1 | 0.0125 | 0.0796 | 0.7143 |
Plasmodium vivax | aspartyl protease, putative | 0.0125 | 0.0799 | 0.7176 |
Brugia malayi | multidrug resistance protein 3 | 0.0125 | 0.0796 | 0.4213 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0125 | 0.0796 | 0.6836 |
Plasmodium vivax | aspartyl proteinase, putative | 0.0156 | 0.1114 | 1 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0125 | 0.0796 | 0.6836 |
Toxoplasma gondii | aspartyl protease ASP1 | 0.0156 | 0.1114 | 1 |
Entamoeba histolytica | P-glycoprotein-2, putative | 0.0125 | 0.0796 | 0.0695 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0156 | 0.1114 | 0.2278 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0087 | 0.0417 | 0.3072 |
Brugia malayi | Phosphatidylcholine:ceramide cholinephosphotransferase 1 | 0.0056 | 0.0108 | 0.0573 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0125 | 0.0796 | 0.6836 |
Toxoplasma gondii | aspartyl proteinase (eimepsin), putative | 0.0156 | 0.1114 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0123 | 0.0782 | 0.414 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0125 | 0.0796 | 0.6836 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0097 | 0.0522 | 0.2763 |
Trypanosoma cruzi | sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional | 0.0533 | 0.4909 | 0.5 |
Brugia malayi | Phosphatidylcholine:ceramide cholinephosphotransferase 2 | 0.0056 | 0.0108 | 0.0573 |
Entamoeba histolytica | P-glycoprotein 5, putative | 0.0125 | 0.0796 | 0.0695 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0125 | 0.0796 | 0.6836 |
Loa Loa (eye worm) | ATP-binding cassette sub-family B member 2 | 0.0125 | 0.0796 | 0.4213 |
Brugia malayi | Phosphatidylcholine:ceramide cholinephosphotransferase 1 | 0.0056 | 0.0108 | 0.0573 |
Plasmodium vivax | aspartyl protease, putative | 0.0125 | 0.0799 | 0.7176 |
Mycobacterium tuberculosis | Probable transmembrane multidrug efflux pump | 0.0125 | 0.0796 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | = 1.56 ug ml-1 | In vitro antibacterial activity against Escherichia coli NIHJ JC-2 | ChEMBL. | 2342057 |
MIC (functional) | = 1.56 ug ml-1 | In vitro antibacterial activity against Escherichia coli NIHJ JC-2 | ChEMBL. | 2342057 |
MIC (functional) | = 6.25 ug ml-1 | In vitro antibacterial activity against Staphylococcus aureus 209P JC-1 | ChEMBL. | 2342057 |
MIC (functional) | = 6.25 ug ml-1 | In vitro antibacterial activity against Pseudomonas aeruginosa 12 | ChEMBL. | 2342057 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.